Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Researcher Dr Jean Marshall Dr Jean Marshall is finding a promising new strategy to block breast cancer.

Learn more

Don’t miss BRA Day Breast Reconstruction Awareness Day

BRA Day is a FREE, annual event that connects you with leading breast reconstruction experts to answer all your questions

Over 30 events across Canada!

Learn more